These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5353959)

  • 41. Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol.
    Bulbrook RD; Herian M; Tong D; Hayward JL; Swain MC; Wang DY
    Lancet; 1973 Mar; 1(7804):628-31. PubMed ID: 4121844
    [No Abstract]   [Full Text] [Related]  

  • 42. [Adverse effects of contraceptives. IV. The problem of potential carcinogenic effects of contraceptive steroids].
    Hertz R
    Gac Med Mex; 1970 Aug; 100(8):849-59. PubMed ID: 5475929
    [No Abstract]   [Full Text] [Related]  

  • 43. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
    Brzezinski A; Schenker JG
    Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of newer progestins as oral contraceptives and in uterine carcinoma.
    GOLDZIEHER JW
    New Physician; 1962 Aug; 11():265-7. PubMed ID: 13899935
    [No Abstract]   [Full Text] [Related]  

  • 45. Basaloid adenomas of the mammary gland in beagle dogs administered investigational contraceptive steroids.
    Kwapien RP; Giles RC; Geil RG; Casey HW
    J Natl Cancer Inst; 1977 Sep; 59(3):933-9. PubMed ID: 894750
    [No Abstract]   [Full Text] [Related]  

  • 46. Serious adverse effects of oral contraceptives and estrogens.
    Med Lett Drugs Ther; 1976 Feb; 18(5):21-2. PubMed ID: 1256357
    [No Abstract]   [Full Text] [Related]  

  • 47. Do hormones cause breast cancer?
    Thomas DB
    Cancer; 1984 Feb; 53(3 Suppl):595-604. PubMed ID: 6362820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Principles of hormonal contraception].
    Hammerstein J
    Arch Dermatol Forsch; 1972; 244():478-90. PubMed ID: 4119339
    [No Abstract]   [Full Text] [Related]  

  • 49. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between estrogen therapy and cancer.
    Geller W
    Mod Treat; 1968 May; 5(3):564-70. PubMed ID: 5690498
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of oral contraceptives on the mammary glands of Rhesus monkeys: a preliminary report.
    Drill VA; Martin DP; Hart ER; McConnell RG
    J Natl Cancer Inst; 1974 May; 52(5):1655-7. PubMed ID: 4208715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The action of estrogens and progestogens in the young female breast.
    Zolfaroli I; Tarín JJ; Cano A
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():204-207. PubMed ID: 29627127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pill, estrogens, and the breast. Epidemiologic aspects.
    Arthes FG; Sartwell PE; Lewison EF
    Cancer; 1971 Dec; 28(6):1391-4. PubMed ID: 5127790
    [No Abstract]   [Full Text] [Related]  

  • 54. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth.
    Longman SM; Buehring GC
    Cancer; 1987 Jan; 59(2):281-7. PubMed ID: 3802015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraceptives and breast cancer: laboratory evidence.
    Shubik P
    IARC Sci Publ; 1985; (65):33-5. PubMed ID: 2417950
    [No Abstract]   [Full Text] [Related]  

  • 56. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.
    Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R
    Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk.
    Sturtevant FM
    Biomed Pharmacother; 1984; 38(8):371-9. PubMed ID: 6525434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Xenoestrogens, biotransformation, and differential risks for breast cancer.
    Rogan E
    Altern Ther Health Med; 2007; 13(2):S112-21. PubMed ID: 17405688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.